Galectin Therapeutics GALT Q1 2025 Annual earnings
Reported May 15, 2025 · Before market open
EPS estimate-$0.20
Next report
Aug 13, 2026 (In 4 weeks)EPS estimate-$0.09
Versus estimates
Revenue
Diluted EPS
Ask the moment Galectin Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Galectin Therapeutics report Q1 2025 earnings?
- Galectin Therapeutics (GALT) reported Q1 2025 earnings on May 15, 2025 before market open.
- What were Galectin Therapeutics's Q1 2025 revenue and EPS?
- Galectin Therapeutics reported diluted EPS of $-0.15 for Q1 2025.
- Did Galectin Therapeutics beat estimates in Q1 2025?
- EPS beat the consensus estimate of $-0.20 by $0.05.
- How did Galectin Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS grew 21.1% from $-0.19.
- Where can I find Galectin Therapeutics's Q1 2025 SEC filings?
- You can read the 10-K periodic report (0001140361-25-011169) directly on SEC EDGAR. The filing index links above go to sec.gov.